ICRM
NPTN

Insight Capital Research & Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Insight Capital Research & Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-46,986
Closed -$660K – 129
2016
Q1 		$660K Buy
+46,986
New +$486K 0.2% 85

Other funds holding NPTN

OMC
Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Insight Capital Research & Management's NPTN Position: Q2 2016 in Review

Insight Capital Research & Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2016, closing a stake of 46,986 shares — an estimated $660K sold.

Insight Capital Research & Management first reported a position in NPTN in Q1 2016 and held it in 1 quarter. The position peaked at $660K in Q1 2016. 133 funds tracked by Wall St. Rank hold NPTN as of Q2 2016.

  • Insight Capital Research & Management reported no remaining NEOPHOTONICS CORP position as of Q2 2016 after selling out during the quarter.
  • Insight Capital Research & Management sold 46,986 NEOPHOTONICS CORP shares in Q2 2016, an estimated $660K.
  • Insight Capital Research & Management first reported a position in NEOPHOTONICS CORP in Q1 2016 and held it in 1 quarter.
  • Insight Capital Research & Management's NEOPHOTONICS CORP position peaked at $660K in Q1 2016.
  • 133 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2016.

Based on Insight Capital Research & Management's 13F filing for Q2 2016, filed 27 Jul 2016.